FOXO4-DRI (Retro-Inverso) is a synthetic, slightly modified version of the standard FOXO4 protein. The modification prolongs half-life of the protein and allows it to interfere with normal FOXO4 function. This interference prevents FOXO4 from binding to the p53 protein, a key regulator that normally keeps damaged senescent cells alive. By disrupting this interaction, FOXO4-DRI enables those dysfunctional cells to undergo apoptosis—effectively clearing them from tissues. Research has shown that removing senescent “zombie” cells can restore tissue function, reduce inflammation, and improve organ health. Studies in animal models indicate that FOXO4-DRI supports cellular rejuvenation, enhances vitality, and may reverse biological signs of aging. Its mechanism also influences oxidative stress, insulin sensitivity, and cell cycle regulation, making it a promising senolytic compound in longevity and regenerative medicine research.